HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Maintaining bond with patients crucial after cancer-directed treatments are no longer beneficial Jennifer Byrne
• AI platform enables oncologists to practice conversations with terminally ill patients Jennifer Byrne
• Gaining a healthy sense of your own mortality Nicholas J. Petrelli, MD, FACS
• Adagrasib active, safe among patients with KRAS G12C-mutated pancreatic, GI tumors Devin McLaughlin
• Beta blocker use does not affect outcomes in immunotherapy-treated HCC Mark Leiser
• Biden relaunches Moonshot with aim to cut cancer deaths by at least 50% in 25 years Ryan Lawrence
• Chronic diseases increasingly common among adult cancer survivors Jennifer R. Southall
• Clinicians often don’t recognize parent challenges in therapeutic relationships Jennifer R. Southall
• Neoadjuvant docetaxel regimen extends OS in locally advanced esophageal cancer Ryan Lawrence
• Hematology and oncology trainees frequently face discrimination, study shows Jennifer R. Southall
• Naive T-cell depletion approach results in lower rates of chronic GVHD after transplant Ryan Lawrence
• Robotic surgery shows benefits vs. laparoscopic surgery for middle, low rectal cancer Jennifer R. Southall
• Smoking cessation after lung cancer diagnosis linked to nearly 30% improvement in survival Ryan Lawrence
• Survival rate rises steadily among patients with relapsed ALL after stem cell transplant Jennifer R. Southall
• Top diet, exercise recommendations for cancer survivors to stay healthy David L. Jennings II, MSN, RN, AGPCNP-BC
• Consortium names associate director of diversity, equity and inclusion
• Community Oncology Alliance elects board members
• Gastrointestinal cancer specialist joins Henry Ford Cancer Institute
• Lung cancer association appoints CEO